Matthias Therapeutics, LLC
CIK 2104165 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Matthias Therapeutics, LLC.
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Jun 1, 2026 | D | 0002104165-26-000003 |
| Jan 7, 2026 | D | 0002104165-26-000002 |